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Abstract.  A  synthetic peptide derived from the 
fibronectin cell-binding domain, GRGDSP,  inhibits the 
adhesion of rat oligodendrocytes to a  number of sub- 
strates.  However, while GRGDSP inhibited the adhe- 
sion of cells in a  short term adhesion assay, the 
presence of the peptide did not prevent cells from ad- 
hering and thriving in longer term culture. The mor- 
phological characteristics of individual cells cultured 
with 0.1  mg/ml GRGDSP were similar to untreated 
cultures; small rounded cell bodies radiating numerous 
fine processes.  Peptide-treated cultures were inhibited 
in their ability to produce myelin specific components. 
The characteristic developmental peak in sulfolipid 
synthesis which occurs both in vivo and in vitro was 
completely inhibited when cells were cultured with 
GRGDSP.  In addition, the synthesis of myelin basic 
protein was inhibited. Ultrastructurally, cells treated 
with GRGDSP showed a  greatly reduced number of 
multilamellar myelin-like membrane figures than 
cells grown without peptide or those grown with 
GRADSP.  Cultured oligodendrocytes did not become 
sensitive to inhibition of sulfolipid synthesis by 
GRGDSP until a period immediately preceding the 
peak in sulfolipid biosynthesis. The effects of pretreat- 
ment with peptide for 5 d before this time were com- 
pletely reversible.  Pretreatment which extended into 
the time of peak myelin synthesis resulted in perma- 
nent impairment in the cell's ability to synthesize sul- 
folipid. The oligodendrocyte's ability to synthesize a 
myelin-like membrane in culture is, in part,  inherent 
since it occurs in the absence of neurons.  The present 
results indicate that myelin membrane production is 
also subject to external control since it appears that 
occupancy of an RGD-dependent cell surface receptor 
during a critical period of in vitro development is re- 
quired for the oligodendrocyte to produce myelin-like 
membrane. 
C 
ELLS in a developing tissue derive information from 
cell surface contact with both other cells and with 
components of the extracellular matrix which guides 
their  positional  and  metabolic  fates.  The  interaction  of 
fibronectin with its cell surface receptors is among the best 
characterized of such cell surface contacts (for reviews see 
references 2, 31, and 40). The region within the fibronectin 
molecule that contains cell-binding activity has been local- 
ized to a tripeptide of arginine-glycine-aspartic acid (RGD 
in single letter code). Synthetic peptides which contain this 
sequence inhibit fibronectin's interaction with its receptors 
and,  when  immobilized,  mimic  fibronectin's  cell-binding 
activity. 
In addition to fibronectin, numerous proteins have been 
shown to bind to cells in an RGD-dependent manner, includ- 
ing vitronectin, fibrinogen, yon Willibrand's factor, throm- 
bospondin, and type I collagen (for reviews  see references 
32 and 33). Cell surface receptors for many of these extracel- 
lular ligands have been purified and characterized (for re- 
views see references 13 and 28). In most cases the receptors 
appear to be specific for a single ligand but in at least one case 
a  single receptor complex binds several different ligands. 
Purified receptors show biochemical similarity both in pri- 
mary sequence and in subunit composition, suggesting that 
they are related members of a group of proteins with roles 
in cell adhesion. 
The extracellular matrix has been shown to regulate tran- 
scriptional activity in several  cultured cell types (5,  18). It 
has been shown that certain transformed cells lack cell sur- 
face fibronectin and that adding fibronectin to these cultures 
restores an untransformed phenotype (3,  10, 41). The fibro- 
nectin receptor of avian cells has been implicated in serving 
as a link between the cytoskeletal system and the extracellu- 
lar environment (9,  11, 29). Fibronectin has been shown to 
have a role in cell migration both in vitro (16, 21) and in vivo 
(6,  26).  However apart  from general  roles  in anchorage, 
maintenance of cell shape, and cell migration, the cellular 
functions which are responsive to occupancy of these RGD- 
dependent receptors remain to be clarified. Recently, evi- 
dence has been presented suggesting that occupancy of the 
RGD-dependent  receptor  Integrin,  previously  known  as 
CSAT antigen, is coupled to the differentiation of myoblasts 
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Integrin,  or with RGD-containing peptides,  are prevented 
from differentiating into myotubes. 
Cell  surface contacts  are  of obvious importance in  the 
developing brain. The cellular complexity of the organ pre- 
cludes the study of many of these interactions. Myelin for- 
mation  in the  immature central nervous system (CNS)  is 
a developmentally regulated event in which the role of cell 
surface contacts is more readily studied since it involves only 
two classes of cells. CNS myelin is formed as an extension 
of the plasma membrane of a single cell type, the oligoden- 
drocyte, which surrounds and ensheathes a  subset of neu- 
ronal processes. The biogenesis of the myelin membrane is 
under strict temporal regulation, occurring chiefly in a brief 
and circumscribed time period during the perinatal develop- 
ment of the brain. Another level of regulation is evident in 
that not all axons are myelinated; some selection of myelin 
competent axons must occur. Cell surface contacts which ac- 
company  myelination  must,  at  the  very  least,  include  a 
specific recognition event between the oligodendrocyte and 
axon. It is conceivable, as well, that aspects of the interaction 
between oligodendrocyte and axon are involved in the tem- 
poral control of myelin biosynthesis. 
We and others have shown that oligodendrocytes main- 
rained  in  culture  in  the  absence  of neurons  synthesize a 
membrane that is myelin-like by both biochemical and mor- 
phological criteria (7,  15,  27,  30,  34,  36).  We  have been 
examining the cell surface events which lead to the ability of 
these cells to produce this myelin-like membrane in culture. 
Building  on  the  knowledge that  oligodendrocytes interact 
with  several  extracellular proteins  in  an  RGD-dependent 
manner (8), we have examined the role that RGD-dependent 
interactions play in the maturation of oligodendrocytes and 
in the development of their myelin-like properties. 
Materials and Methods 
Materials 
Polystyrene 24-well plates, both treated and untreated for tissue culture use, 
were manufactured by Linbro and obtained from Flow Laboratories (Mc- 
Clean, VA). Calf serum was obtained from Hyclone (Logan, UT). [sSS]H2SO4 
was purchased from ICN. Antisera to myelin basic protein was the gift of 
Dr. Scott D. Linthicum, Department of Pathology, University of Texas Med- 
ical School (Houston, TX). All other chemicals were from standard com- 
mercial suppliers. 
Me~o~ 
Cell Culture.  Purified oligodendrocytes were prepared from neonatal rat 
cerebral cortex by a modification of the method of McCarthy and de Vellis 
(22), as described (30). This method is based on the differential adhesion 
of oligodendrocytes and astrocytes in mixed glial cultures. Oligodendrocytes 
are released into the culture medium upon extended shaking, while astro- 
cytes remain attached to the plastic surface. Oligodendrocytes released into 
culture medium were filtered through a 20 ~tM stainless steel mesh (Cellec- 
tor, Bellco, Vineland, NJ) and were replated at a density of ",,5  ×  10S/well 
in 24-well plates on either tissue culture treated plastic or on astroglial ma- 
trix (AGM)  1. AGM was prepared by water lysis of ~  glial cells (8).  After 
allowing cells 8 h to attach to the surface, as much media was removed as 
possible without uncovering and disturbing the cell layer. The total volume 
per well was then adjusted to 1.0 ml with fresh media. Cultures were main- 
tained in DME/FI2 supplemented with 5% calf serum. Cells were grown 
in the presence of various peptide inhibitors by addition of an aliquot of a 
10×  stock made up in the same media. 
1. Abbreviation used in this paper:  AGM, astroglial matrix. 
We routinely date our cultures with the convention of "equivalent brain 
age." We use this to mean the age of the rats at the time of dissection plus 
the number of days in culture (30). All references to the age of cells make 
use of this convention. Oligodendrocytes are isolated as a pure population 
from mixed glial cells on day 9. 
SDS-PAGE/Immunoblotting.  polyacrylamide slab gels were prepared 
with SDS using the buffer system of Laemmli (17). Samples to be analyzed 
were prepared in buffer containing 62.5 mM Tris, 3% SDS,  10% glycerol, 
5%  I]-mercaptoethanol, pH 6.8.  Samples were heated at 100°C for 5 min 
and run on 15%  gels with a 4.5%  stacking layer.  Gels were silver stained 
by the method of Merril  (25). 
Western blot  analysis was  carried  out  by  electrophoretic  transfer to 
nitrocellulose membranes (Bio-Rad Laboratories, Richmond, CA) accord- 
ing to the method of Towbin (37). The membranes were blocked in PBS with 
2 % nonfat milk and 20 % methanol. The antibody incubations and color de- 
velopment were carried out as described elsewhere (8). 
Metabolic Labeling. Cells grown in 24-well plates on AGM were labeled 
with 2-5  ~tCi [35S]H2SO4 in 0.5 ml per well low sulfate DME/F12  with 
1% CS. The labeling time was 16 h unless otherwise noted. When the label- 
ing time was extended beyond 24 h, the low sulfate DME was supplemented 
with 2%  calf serum and the volume per well was increased to  1.0 ml. To 
harvest cells, the cell layer was washed once with PBS then extracted with 
0.4 ml 4 M guanidine HCI, 50 mM EDTA, 50 mM sodium acetate, 0.1 M 
aminocaproic acid, 1.0% CHAPS, pH 5.8. This extract was sonicated to dis- 
perse the cellular material. An aliquot of this extract was removed for pro- 
tein determination and the remainder was extracted for lipid analysis with 
10 vol of isopropanol:hexane (2:3).  The lipid extracts were vortexed and 
the resulting two phase system was clarified by centrifugation. A portion 
of the upper phase was transferred to scintillation vials to measure [sSS]sul- 
folipid. Analysis of the lipid extract by TLC on silica G plates revealed that 
95% of the total radioactivity co-migrated with a  sulfatide standard. 
Synthetic Peptides.  Peptides were prepared by Dr. Janice Young of the 
UCLA Peptide Synthesis Facility in the Department of Biological Chemis- 
try.  The peptides were synthesized on an Applied Biosystems, Inc. (Foster 
City, CA) 430A Peptide Synthesizer using version 1.3 software.  The peptides 
were cleaved from the resin with anhydrous hydrogen fluoride with 10% ani- 
sole. The cleaved peptides were extracted with ether, dissolved in 1% acetic 
acid and lyophilized. Peptides were either used without further purification 
or were additionally purified by two cycles of gel filtration on Sephadex G10 
(Pharmacia,  Upsalla,  Sweden)  in H20,  followed by lyophilization and a 
wash with cold ether. These additional purification steps did not alter the 
activity in either adhesion or long term culture experiments. 
Electron  Microscopy. Cell cultures grown in 24-well plates on plastic 
coverslips (Thermanox, Lux) were washed twice.in PBS. The cells were 
fixed with 2 % paraformaldebyde and 2 % glutaraldehyde in 0.1 M cacodyl- 
ate, pH 7.2, for 48 h at 4°C. Cells were postfixed in 1% OsO4 in the same 
buffer, dehydrated, and spurr embedded. The sections were examined on 
a JEOL  100-EX electron microscope. 
Myelin  Isolation.  Myelin was isolated from cultured oligodendrocytes 
and from whole brain by a procedure originally developed for whole brain 
(1).  Oligodendrocytes  were  grown  in  75  cm  2 flasks,  harvested at  24  d 
"equivalent brain age" by scraping into 0.88 M  sucrose, and homogenized 
in a tight fitting Dounce homogenizer. The final volume was 2.0 ml per flask. 
These homogenates were transferred to centrifuge tubes and each tube was 
overlaid with 2.0 ml 0.34 M  sucrose. These two step gradients were centri- 
fuged at 75,000 g  for 45 min in a SW 60 rotor.  The material accumulated 
at the interface was collected and diluted with 10 vol of cold distilled water. 
The collected membranes were Dounce homogenized and pelleted at 20,000 g 
for 20 min. This osmotic shock procedure was repeated and the final pellet 
was saved as the crude myelin fraction. Myelin from whole brain was pre- 
pared at the same time from 24-d-old littermates of those animals used to 
prepare the primary cultures. The percentage of protein recovered in the 
myelin-like fractions relative to that in the cell homogenates was used to 
quantitate membrane production under the various conditions. 
Protein Determination.  Protein values were estimated by the bicincho- 
ninic acid method using a kit supplied by Pierce (Rockford, IL) with BSA 
as standard (35). 
Results 
Inhibition of  Sulfolipid Synthesis by GRGDSP 
Oligodendrocytes adhere to a number of different substrates 
in an RGD-dependent manner. However, these cells can be 
The Journal of Cell Biology, Volume 107,  1988  1552 Figure 1. 
TIME (Ooys,"equivolent  brain  age") 
Inhibition  of developmental  pattern  of [3~S]sulfolipid 
0 
x  6.0- 
.S 
o 
o  & 
o,  5.0- 
E 
g 
40- 
3.0- 
0 
• :  2.0- 
Q 
a. 
.J 
~o- 
...J 
I 
g 
synthesis by GRGDSP. Oligodendrocytes obtained from mixed glial 
cells were plated on AGM. The cultures were supplemented with 
0.1 ml of 1.0 mg/ml GRGDSP in DME/F12  with 5% calf serum 
(o) or with 0.1 ml DME/F12 with 5 % calf serum (e). The cultures 
were fed every other day by replacing one half the total volume of 
each  well  with  either  culture  medium  alone  or  medium  sup- 
plemented with GRGDSP, maintaining the initial concentration of 
peptide. Cultures were labeled for 16 h in low sulfate DME contain- 
ing  1% calf serum and 4.0  laCi [35S]H2SO4/ml beginning on the 
day shown. The cell layer was washed, solubilized and lipid extracted 
as described in Materials and Methods. Each bar represents the av- 
erage of 3 separate determinations and the variation between sam- 
ples was less than  10%. 
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Figure 2. Specificity of peptide inhibition of [35S]sulfolipid synthe- 
sis. Oligodendrocytes plated on AGM were cultured with no peptide 
additions until day 15, at which time they were supplemented with 
the appropriate peptide solution. Cells were grown in media alone 
(A), or in media with 0.1 mg/ml GRGDSP (B), 0.1 mg/ml GRADSP 
(C), or 0.1 mg/ml VYPNGA (D). The cells were kept in the pres- 
ence of peptide for three days until day 18 with no further media 
change. On day 18 the cells were labeled for 16 h in the absence 
of peptide, harvested, and extracted as described in Materials and 
Methods. Each bar represents the average of 3 wells and the error 
bars indicate SD. 
maintained in culture in the presence of a concentration of 
GRGDSP which does not cause a significant amount of cell 
loss. Cells grown with 0.1 mg/ml GRGDSP show only slight 
differences  in  overall  morphology.  Notable  among  these 
changes is a reduced tendency of cells to aggregate into the 
multicellular clusters which have often been observed with 
oligodendrocytes  in culture  (39).  Despite no gross differ- 
ences in individual cell morphology, peptide-treated cultures 
did show marked differences in their ability to produce my- 
elin specific components. As we have previously shown, pure 
oligodendrocytes maintained in culture progress through a 
characteristic developmental change in the ability to produce 
the myelin-enriched galactolipids sulfatide and cerebroside 
(30). In addition to these galactolipids, these cells synthesize 
the  major myelin proteins,  myelin basic protein  and  pro- 
teolipid protein as well as several minor myelin protein con- 
stituents.  Moreover,  these  cultures  assemble these  myelin 
components, in the absence of neurons, into a loosely com- 
pacted, multilamellar myelin-like membrane. The peak syn- 
thetic  levels  determined  in  culture  when  corrected  for 
"equivalent brain age" are similar to those determined in vivo 
(4, 23). In the experiment shown in Fig.  1, the biosynthetic 
peak for  pSS]sulfolipid  in  untreated  cultures  occurred  on 
day 16.  When cells were grown in the presence 0.1  mg/ml 
GRGDSP from the time of plating as pure oligodendrocytes 
and labeled after various times in culture,  the normal de- 
velopmental pattern of sulfatide  synthesis  was completely 
blocked  (Fig.  1).  Sulfolipid  synthetic  levels  for  peptide- 
treated cultures never exceeded the baseline level of the un- 
treated controls. We have expressed values of [35S]sulfolip- 
id  synthesis  per unit  protein  as  an  approximation  of cell 
number. 
As shown in Fig. 2, this inhibition of sulfolipid synthesis 
is specific to GRGDSP. Two other peptides were examined 
for their ability to inhibit sulfolipid synthesis. One of these 
peptides was a hexapeptide with a single substitution of ala- 
nine for glycine within the RGD region.  The other peptide 
was an unrelated hexapeptide. These peptides caused little or 
no inhibition of sulfolipid synthesis. 
Timing of GRGDSP Effects 
To determine the length of exposure to GRGDSP required for 
maximal inhibition of sulfolipid synthesis, cultures of pure 
oligodendrocytes were treated for up to 7 d in media contain- 
ing  0.1  mg/ml  of  the  peptide.  Cells  were  labeled  with 
[35S]H2SO4 on day 17 for 16 h in media that did not contain 
the peptide. As shown in Fig. 3, sulfolipid synthesis was re- 
duced to 7-15 % of control values with 3-5 d ofpretreatment, 
although even a 1-d pretreatment had a significant inhibitory 
effect. 
Oligodendrocytes were viable in culture for several months 
and continued to synthesize the myelin-enriched galactolip- 
ids throughout this time. The cells were variably inhibited 
by peptide treatment depending on the age of the cultures. 
While  measurable  levels  of  sulfolipid  were  produced  in 
newly plated cells, this basal level of synthesis did not appear 
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Figure 3. Effects  of pretreatment of oligodendrocytes with GRG- 
DSP on [35S]sulfolipid synthesis. Oligodendrocytes were plated on 
AGM (open bars) or on plastic (hatched bars) and allowed  8 h to 
adhere before media was partially removed and replaced with fresh 
media. Peptides solutions were added to the cultures from 1 to 7 d 
before labeling, which was carried out on day 18. The values shown 
for 0 days pretreatment were obtained from cultures  which con- 
tained no added peptide.  In all cases, the cells were labeled for 
16 h,  harvested,  and  extracted  as  described  in  Materials  and 
Methods. Each bar represents the average of 3 wells and the error 
bars indicate SD. 
Peptide treated cultures were then handled in three different 
ways: (a) cells were kept in the presence of GRGDSP for the 
duration of the experiment (including  the labeling period); 
(b) peptide was removed on day 14 for up to 6 d; or (c) pep- 
tide was removed on day 16 and cultured for an additional 4 d. 
The synthesis of [35S]sulfolipid in cells grown in the pres- 
ence of peptide was depressed  relative to controls by 50% 
in the day 14-16 labeling period, by 70% in days 16-18, and 
by 69%  in days  18-20.  When the peptide was removed on 
day 14, the synthesis of [35S]sulfolipid was essentially at the 
level of untreated  controls.  When the peptide was removed 
from cultures on day 16, the synthesis of sulfolipid remained 
depressed  to the  level of cultures  continually  treated  with 
peptide.  Since  a  maximal  inhibition  of [35S]sulfolipid  syn- 
thesis was seen after only 3-5 d  of treatment with peptide, 
it appears that this finding is not simply the result of longer 
exposure  to  the  peptide,  but  of exposure  at  some  critical 
period of the cells in vitro development. Cells treated in such 
a way never returned to control levels of synthesis even if al- 
lowed up to 10 d to recover. Further,  if the peptide was re- 
moved at any point after day 16, the oligodendrocyte was also 
permanently impaired in its ability to synthesize sulfolipid in 
vitro. 
Inhibition of  Myelin-like Membrane and Myelin Basic 
Protein Synthesis by GRGDSP 
It is conceivable that the effect of the GRGDSP peptide on 
sulfolipid  synthesis  is due  to a  direct inhibition  of the en- 
zymes of sulfatide biosynthesis or on altered sulfate uptake 
to be inhibited by GRGDSP. Inhibition was not apparent until 
days 14-16. While cells were impaired by peptide treatment 
at any age in culture after this time, the extent of inhibition 
was greatest when the cells were labeled during the develop- 
mental peak in  sulfolipid  synthesis (data not shown). 
While we have shown that the oligodendrocytes adhered in 
an RGD-dependent manner to AGM and not to plastic (8), 
cells plated on either plastic or AGM showed a decrease in 
sulfolipid  synthesis  when  cultured  in  the  presence  of the 
RGD-containing hexapeptide (Fig. 3). This result might sug- 
gest that it is not the interaction of oligodendrocytes with a 
component of the AGM  which  is inhibited  by culture with 
peptide,  but  perhaps,  the  interaction  of oligodendrocytes 
with each other (see Discussion). 
In all of the above labeling  experiments,  cells were pre- 
treated with peptide and then labeled for 16 h  in media that 
did not contain peptide.  To further measure the rapidity of 
the sulfolipid inhibition,  cells were cultured without peptide 
until  the  time that lipid  synthesis  was maximal.  The cells 
were  then  labeled  in  media  supplemented  with  0.1  mg/ml 
GRGDSP.  Cultures  were  labeled  for up to 24  h  and  com- 
pared with control cultures  which contained no added pep- 
tide. Inhibition of sulfolipid synthesis was evident after only 
2-4 h  of exposure to peptide  (Fig.  4). 
Reversibility of Inhibition of  Sulfolipid Synthesis 
As shown in Fig.  5, the inhibition of [35S]sulfolipid  synthe- 
sis was reversible. Oligodendrocytes were cultured with and 
without added GRGDSP from the time of plating on day 9. 
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Figure 4. Time course of inhibition of [35S]sulfolipid synthesis by 
GRGDSP. Oligodendrocytes were cultured for 1 wk until  day 16, 
in the absence of GRGDSP. The cultures were labeled starting on 
day 16 for 1 to 24 h in media that contained no peptide (e) or in 
media that contained 0.1 mg/ml GRGDSP (0). [35S]Sulfolipid syn- 
thesis was determined as described in Materials and Methods. Each 
bar represents the average of 3 separate determinations and the vari- 
ation  between  samples  was  less  than  10%.  The  [35S]sulfolipid 
values were not expressed relative to protein content since the treat- 
ment caused no noticeable cell loss and the total protein content of 
each well did not change over the course of the experiment. 
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ability to produce a  myelin-like membrane in culture.  We 
therefore examined more directly the production of myelin- 
like membranes in cultures treated with GRGDSP. Cultured 
oligodendrocytes were grown either in media supplemented 
with 0.1  mg/ml GRGDSP from day 14 to day 18,  in media 
supplemented with 0.1 mg/ml GRADSP from day 14 to day 
18, or without added peptide.  All cultures were maintained 
in media without peptide from day 18 to day 24 at which time 
they were harvested and used to prepare a crude myelin-like 
membrane fraction.  There is a  small degree of cell loss in 
GRGDSP-treated cultures which was minimized by limiting 
the length of exposure to peptide to only 4 d. In the experi- 
ment shown in Fig.  6,  GRGDSP-treated cultures contained 
94% of the total protein content of untreated controls. How- 
ever, when corrected for differences in the amount of protein 
in the starting homogenate, the protein content of the myelin- 
like membrane fraction isolated from GRGDSP-treated cul- 
tures was 27 % of that derived from untreated cultures.  For 
GRADSP-treated cultures this value was 75 %. 
The  content  of myelin  basic  protein  in  the  myelin-like 
membrane fractions of these cultures is shown in Fig. 6, lane 
c. There is a marked reduction in myelin basic protein con- 
tent in GRGDSP-treated cultures relative to either GRADSP- 
treated  or untreated  cultures.  The content of myelin basic 
protein in the total cellular homogenates of the cultured oligo- 
dendrocytes was decreased to the same extent in GRGDSP- 
treated cultures relative to control cultures (data not shown), 
suggesting that the peptide's effect is not simply to alter the 
buoyant  density  properties  of  the  myelin-like  membrane 
formed. 
Figure 6.  Inhibition of myelin-like membrane production and of 
myelin basic protein synthesis by GRGDSP. Oligodendrocytes  were 
maintained in  75 cm  2 flasks from day 9 until day 24.  Cultures 
treated with peptide were kept in the presence of  0.1 mg/ml of either 
GRGDSP or GRADSP from days 14 to 18. The cells were harvested 
and  used for  myelin isolation as  described  in  Materials  and 
Methods. Whole brain from iittermates of the animals used in the 
primary dissection was treated in the same way. Silver-stained sam- 
ples of the total homogenate (lane a), of the crude myelin-like frac- 
tion  (lane b),  and  western blots of crude  myelin-like fractions 
probed with antibodies to myelin basic proteins (lane c) are shown. 
For the samples isolated from cultured cells, 2.5 I.tg  of total protein 
was applied to lane a. The myelin-like membrane fractions isolated 
for each treatment were suspended in a constant volume relative to 
the amount of protein in the starting homogenate. The same percent- 
age of these samples (not the same amount of protein) was run in 
lanes b and c. 
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Figure 5.  Reversibility of GRGDSP inhibition of [35S]sulfolipid 
synthesis. Oligodendrocyte  cultures were plated on AGM and were 
maintained in media without added peptide (open bars), with 0.1 
mg/ml GRGDSP for the duration of the experiment, days 9 to 20, 
(stippled bars),  with 0.1  mg/ml GRGDSP from days 9 to 14 and 
then in media that did not contain peptide (hatched bars), or with 
0.1 mg/ml GRGDSP from days 9 to 16 and then in media that did 
not contain peptide (solid bars). The cells were labeled for 48 h in 
low sulfate DME with 2% calf serum in a total volume of 1.0 ml. 
For cultures which were kept in the presence of peptide throughout, 
the labeling media was supplemented with peptide to a final concen- 
tration of 0.1 mg/ml. Each bar represents the average of 3 separate 
determinations and the  variation between samples was less than 
10%. 
Cultured oligodendrocytes produce a multilamellar mye- 
lin-like  membrane in  the absence of neurons,  that can be 
readily detected by using electron microscopy. In cultures 
grown with the control peptide (GRADSP) or without pep- 
tide these multilamellar membranes are evident in the prox- 
imity of nearly every cell examined. As shown in Fig. 7 A, 
in cultures treated with GRADSP for 4 d between days  14 
and  18,  these  membranes  were very prominent and com- 
monly displayed as many as 10 semi-compacted lamellae. In 
contrast,  in  cultures  treated  with  GRGDSP for this  same 
length of  time, multilamellar membrane was very infrequently 
observed. Less than 20% of  the treated oligodendrocytes dis- 
played any  multilamellar  membrane  in  their  extracellular 
surroundings and, when it was observed, the lamellae never 
exceeded  2-3  layers.  The  micrograph shown in  Fig.  7  B 
represents an oligodendrocyte from the minor population of 
cells that had extracellular figures.  Note the reduced amount 
and the reduced complexity of the membranous elements. 
Discussion 
We are interested in the cell surface adhesion and signaling 
events which precede and accompany myelination of neu- 
ronal axons by oligodendrocytes. Recently,  in  a  system in 
which oligodendrocytes isolated from adult ovine brain were 
cultured  either  in  suspension or attached  to a  polylysine- 
treated surface, nonspecific adhesion was shown to influence 
the functional state of the cells.  The synthesis of the major 
myelin proteins,  proteolipid protein and myelin basic pro- 
Cardwell and Rome II GRGDSP Inhibits Synthesis of Myelin  1555 Figure 7. Ultrastructure of peptide-treated oligodendrocytes. Oligodendrocytes were grown on coverslips in 24-well plates. Cells were kept 
in the presence of 0.1 mg/ml GRADSP (A) or GRGDSP (B) from days 14 to 18. The cells were fixed on day 24 and processed as described 
in Materials and Methods. The field shown in A is typical of cultures without added peptide or treated with GRADSP (i.e., nearly every 
cell is found to have numerous myelin-like figures in the surrounding extraceilular space). The field in B shows an example of the minor 
population of cells which have surrounding myelin-like figures. Bars:  (A and B)  1.5  ~m; (insets) 250 nM. 
The Journal of Cell Biology, Volume 107, 1988  1556 tein, was enhanced and the phosphorylation of myelin basic 
protein was increased in adherent cells (38, 42). Oligoden- 
drocytes are capable of forming adhesive associations with 
substrate by both RGD-dependent and independent (e.g., via 
charge  interactions  with  polyion-coated surfaces)  mecha- 
nisms (8). By culturing cells with a level of GRGDSP which 
does not cause significant cell detachment, we have been able 
to specifically perturb the RGD-dependent contacts and to 
examine the contributions of these interactions to the devel- 
opment of myelin-like properties in culture. 
We have made extensive use of sulfolipid as a marker for 
myelination.  In cultures of neonatal  rat oligodendrocytes, 
>95 % of the total [35S]sulfolipid synthesized is sulfatide, a 
sulfated galactolipid with a very limited tissue distribution 
(12). In the brain, sulfatide is essentially restricted to the my- 
elin membrane and is widely used as a marker for both my- 
elin and for the oligodendrocyte. We have used the measure- 
ment of sulfolipid as a convenient and accurate estimate of 
sulfatide synthesis and of myelin-like membrane synthesis. 
The effects of the GRGDSP peptide on long term cultures 
of oligodendrocytes were not due to cytotoxicity. Control 
peptides synthesized under the same protocol had little or no 
effect on the parameters measured. Extensive purification of 
the active peptide by gel filtration and ether extraction caused 
little or no decrease in its inhibitory activity. Furthermore, 
cells cultured in the presence of peptide had typical oligoden- 
drocyte morphology and remained viable for the duration of 
our observation, up to day 28. 
Oligodendrocytes produced measurable amounts of sul- 
folipid for as long as they were maintained in pure culture 
(in  our  experiments  pure  oligodendrocytes were  isolated 
from mixed glial cultures on day 9).  Superimposed on this 
basal level of synthesis is a biosynthetic peak, the timing of 
which immediately precedes the appearance of myelin fig- 
ures in the cultures. GRGDSP completely inhibited the char- 
acteristic biosynthetic peak observed with these cells in cul- 
ture, though the cells continued to synthesize sulfolipid at a 
basal level (Fig.  1). 
The synthesis of sulfolipid was not inhibited by GRGDSP 
until the time that sulfolipid synthesis began to peak on days 
14-16.  After cells became sensitive to  inhibition on days 
14-16,  they remained so, although they were most suscepti- 
ble during the time that lipid synthesis was maximal. More- 
over, treatment with peptide was completely reversible if the 
peptide was removed on or before day 14. Treatment for 5 d 
from day 9 to 14 did not appear to effect the subsequent de- 
velopment of myelin properties, causing neither a diminu- 
tion nor a delay in the observed biosynthetic peak. Cultures 
treated after day 14 with peptide were permanently impaired 
in their ability to synthesize sulfolipid. 
The effects of the GRGDSP peptide were not confined to 
sulfolipid synthesis, we also observed an overall reduction in 
production of myelin-like membrane, assayed both biochem- 
ically and morphologically. Myelin-like membrane isolated 
from cultured cells was similar to whole brain when com- 
pared on SDS-PAGE, although the membrane from cultured 
cells contained many minor bands not found in samples from 
whole brain and which did not seem to be effected by peptide 
treatment.  Both membrane isolated from whole brain and 
from cultured cells was enriched in the myelin specific pro- 
teins MBP and proteolipid protein. The GRGDSP peptide 
caused a substantial reduction both in the amount of overall 
membrane proteins produced and in the amount of MBP de- 
tected by western blotting.  The morphological differences 
were even more dramatic; peptide-treated oligodendrocytes 
produced  far  fewer multilamellar  membrane  figures than 
control cultures and those membranes were both less com- 
plex and less compacted. 
The results summarized above suggest that the biochemi- 
cal changes  responsible for the production of myelin-like 
membrane appear to be dependent on occupancy of the cell's 
RGD-dependent receptor during a critical period of in vitro 
development. This critical period occurs between days  14 
and 16 and immediately precedes the time of peak lipid syn- 
thesis (8). When cultures were treated with GRGDSP from 
days 14 to 18, then cultured without peptide until day 24, they 
were inhibited in the production of myelin-like membranes, 
even though the time of peptide treatment preceded the time 
when myelin-figures became prominent in the cultures. In a 
culture system in which oligodendrocytes are maintained in 
a chemically defined medium, the cells show the characteris- 
tic peak in sulfolipid synthesis that we and others have ob- 
served, only when cultured with thyroxine (14). It is interest- 
ing to note that there also appears to be a  critical period 
which immediately precedes the time of  peak synthesis when 
thyroxine is absolutely required. 
GRGDSP inhibited the adhesion of oligodendrocytes to 
AGM, but had no effect on binding to polystyrene, which was 
not modified for tissue culture use. However, given sufficient 
time, oligodendrocytes adhered to unmodified polystyrene 
and  developed the  same  myelinogenic properties as  cells 
grown on AGM. The observation that cells plated on plastic 
were  inhibited  in  sulfolipid  synthesis  by  the  addition  of 
GRGDSP and the fact that peptide treatment seemed to effect 
the aggregation of cells might suggest that the interaction dis- 
rupted by peptide treatment was not between cell and sub- 
strate, but rather between cells. Oligodendrocytes have been 
shown to interact extensively with other oligodendrocytes  via 
tight junctions both in vivo (19) and in culture (20). The ten- 
dency of  oligodendrocytes to cluster has been noted by others 
working with a similar culture system (39). It is conceivable 
that these intercellular associations are functionally impor- 
tant to the oligodendrocyte and that they are mediated by 
RGD-dependent interactions. While the bulk of the informa- 
tion on RGD interactions has been derived from studies on 
cellular interactions with extracellular matrix constituents, 
there is also evidence that these interactions are important 
in specific cell-cell associations. A group of leukocyte cell 
surface  proteins,  the  LFA-1, Mac-l,  and  p150,95  family, 
which shows extensive homology to each other as well as to 
the receptors for fibronectin and vitronectin, has been shown 
to be involved in antigen-independent binding between leu- 
kocytes as well as leukocyte binding to capillary endothelial 
cells (13). 
Another explanation for the observation of inhibition of 
sulfolipid synthesis in cells on plastic as well as AGM is that, 
while AGM is the product of cultures which contain both 
oligodendrocytes  and  astrocytes,  oligodendrocytes  them- 
selves may synthesize the protein component of AGM which 
binds cells in an RGD-dependent manner.  However, when 
pure cultures of oligodendrocytes were grown for 7 d and 
then used to prepare a matrix by the same water lysis proce- 
dure used to make AGM, the surface did not promote adhe- 
sion  above  the  level  of serum-treated  plastic  (Cardwell, 
Cardwell and Rome II GRGDSP Inhibits Synthesis of Myelin  1557 M.  C., and L. H. Rome, unpublished observation).  While the 
component of AGM does not appear to be derived from se- 
rum, serum-treated  plastic does exhibit ,o16% of the RGD- 
dependent binding of AGM. Perhaps this level of binding is 
sufficient for the cells to develop their myelinogenic proper- 
ties. If serum provides a soluble ligand for the cell surface 
component of the oligodendrocyte,  one would expect cells 
grown on either plastic or AGM  to be equally effected by 
peptide treatment. 
We have demonstrated the importance of RGD-dependent 
contacts in the development of myelin properties in culture. 
More detailed analysis of the role that RGD interactions  play 
in  myelination  awaits  purification  of the  oligodendrocyte 
receptor.  Questions of immediate interest include the local- 
ization of the receptor on the cell surface. Does it for exam- 
ple localize to the tips of the growing processes which one 
might expect to be the first part of the oligodendrocyte to 
make contact with a receptive axon. What are the changes 
which occur in the cell during day 9 to day  16 which make 
it susceptible to inhibition by peptide?  Since the adhesion of 
newly  isolated  oligodendrocytes  (day  9)  is  inhibited  by 
GRGDSP, the receptor is present on the cell surface at a time 
before the cells become  sensitive  to the  inhibition of sul- 
folipid synthesis. The changes which confer this sensitivity 
may involve an increase in receptor number and/or the func- 
tional  association  of the  receptor with an  effector system 
responsible for linking cell surface adhesion/signaling events 
to the production of myelin membrane components. 
This work was supported by United States Public Health Service (USPHS) 
grant No. HD-06576.  L. H. Rome is the recipient of an American Cancer 
Society Faculty Research Award. M. C. Cardwell is supported as a predoc- 
toral trainee on USPHS grant  No.  HD-07032. 
Received for publication 19 January  1988, and in revised form 6 June 1988. 
References 
1. Agrawal, H. C., g. M. Burton, M. A. Fishman, g. F. Mitchell, and A, L. 
Prensky.  1972. Partial characterization of a new myelin protein compo- 
nent. J.  Neurochem.  19:2083-2089. 
2. Akiyama, S. K., andK. M. Yamada. 1987. Fibronectin. Adv. Enzymol. 59: 
1-57. 
3. Ali, I. U., V. M. Mautner, R. Lanza, and R. O. Hynes.  1977. Restoration 
of normal morphology, adhesion and cytoskeleton by addition of a trans- 
formation-sensitive surface protein.  Cell. 11:115-126. 
4. Benjamins, J. A., and M. E. Smith.  1984. Metabolism of myelin. In My- 
elin.  P.  Morell,  editor.  Plenum Press,  New York.  225-258. 
5. Ben-Ze'ev, A., G. S. Robinson, N. L. R. Bucher, and S. R. Farmer.  1988. 
Cell-cell and cell-matrix interactions differentially regulate the expression 
of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. 
Proc. Natl. Acad.  Sci. USA. 85:2161-2165. 
6. Boucaut, J.-C., T. Darribere,  T. J. Poole, H. Aoyama,  K. M. Yamada, 
and M. P. Thiery.  1984. Biologically active synthetic peptides as probes 
of embryonic development: a competitive peptide inhibitor of fibronectin 
function inhibits gastrulation in amphibian embryos and neural crest cell 
migration in avian embryos.  J.  Cell Biol. 99:1822-1830. 
7. Bradel, E. J., and F. P. Prince.  1983. Cultured neonatal rat oligodendro- 
cytes elaborate myelin membrane in the absence of neurons. J. Neurosci. 
Res.  9:381-392. 
8. Cardwell, M. C., and L. H. Rome. 1988. Evidence that an RGD-dependent 
receptor mediates the binding of oligodendrocytes to a novel ligand in a 
glial-derived matrix. J.  Cell Biol. 107:1541-1549. 
9. Chen,  W.-T.,  T.  Hasegawa,  E.  Hasegawa,  C.  Weinstock,  and  K.  M. 
Yamada.  1985. Development of cell surface linkage complexes in cul- 
tured fibroblasts. J.  Cell Biol.  100:1103-1114. 
10.  Chen, W.-T., J. Wang, T. Hasegawa, S. S. Yamada, and K. M. Yamada. 
1986. Regulation of fibronectin receptor distribution by transformation, 
exogenous fibronectin,  and synthetic peptides. J.  Cell Biol. 103:1649- 
1661. 
11. Enders, G. C., J. H. Henson, and C. F. Millette.  1986. Sertoli cell binding 
to isolated testieular basement membrane. J.  Cell Biol.  103:1109-1119. 
12.  Hakomori, S. 1983. Chemistry of glycosphingolipids. In Sphingolipid Bio- 
chemistry. J. N. Kanfer and S. Hakomori, editors.  Plenum Press, New 
York.  97-99. 
13.  Hynes,  R.  O.  1987. Integrins:  a family of cell surface  receptors.  Cell. 
48:549-554. 
14.  Koper, J. W., R. C. Hoeben, F. M. H. Hochstenbach, L. M. G. van Golde, 
and M. Lopes-Cardozo.  1986. Effects of triiodothyronine on the synthe- 
sis of sulfolipids by oligodendrocyte-enriched  cultures.  Biochim.  Bio- 
phys.  Acta. 887:327-334. 
15.  Knapp, P. E., W. P. Bartlett, and R. P. Skoff. 1987. Cultured oligodendro- 
cytes mimic in vivo phenotypic characteristics:  cell shape, expression of 
myelin-specific antigens, and membrane production. Dev. Biol. 120:356- 
365. 
16.  Lacovara, J., E. B. Cramer, and J. P. Quigley. 1984. Fibronectin enhance- 
ment of  directed migration of BI 6 melanoma cells. Cancer Res. 44:1657- 
1663. 
17.  Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of 
the head of bacteriophage T4. Nature  (Lond.). 277:680-685. 
18.  Li, M. L., J. Aggeler, D. A. Farson, C. Hatier, J. Hassel, and M. J. Bissel. 
1987. Influence of a reconstituted basement membrane and its compo- 
nents on casein gene expression and secretion in mouse mammary epithe- 
lial cells. Proc.  Natl. Acad. Sci. USA. 84:136-140. 
19.  Massa, P. T., and E. Mugnaini.  1982. Cell junctions and intramembranous 
particles  of astrocytes  and  oligodendrocytes:  a  freeze-fracture  study. 
Neuroscience.  7:523-538. 
20.  Massa, P. T., and E. Mugnaini.  1985. Cell-cell interactions and character- 
istic plasma membrane features of cultured rat glial cells. Neuroscience. 
14:695-709. 
21.  McCarthy, J. B., and L. T. Furcht.  1984. Laminin and fibronectin promote 
the haptotactic migration of B16 mouse melanoma cells in vitro. J.  Cell 
Biol.  98:1474-1480. 
22.  McCarthy, K. D., and J. de Vellis.  1980. Preparation of separate astroglial 
and oligodendroglial cell cultures from rat cerebral tissue. J.  Cell Biol. 
85:890-902. 
23.  McKhann, G. M., and W. Ho.  1967. The in vivo and in vitro synthesis of 
sulphatides during development.  J.  Neurochem.  14:717-724. 
24. Menko, A. S., and D. Boettinger. 1987. Occupation of  the extracellular ma- 
trix  receptor,  Integrin,  is a control  point for myogenic differentiation. 
Cell. 51:51-57. 
25.  Merril,  C.  R.,  D.  Goldman,  S.  A.  Sedman,  and  M.  H.  Ebert.  1980. 
Ultrasensitive stain for proteins  in polyacrylamide gels shows regional 
variation in cerebrospinal fluid proteins. Science (Wash. DC). 211 : 1437- 
1438. 
26.  Naidet, C., M. Semeriva, K. M. Yamada, and J. P. Thiery.  1987. Peptides 
containing the cell-attachment recognition  signal Arg-Gly-Asp prevent 
gastrulation in Drosophila  embryos. Nature  (Lond.). 325:348-350. 
27.  Poduslo,  S. E., R. H.  Miler,  and J.  S. Wolinsky.  1982. The production 
of a membrane by purified oligodendroglia maintained in culture.  Exp. 
Cell Res.  137:203-215. 
28.  Pytela, R. M. D. Pierschbacher, S. Argraves, S. Suzuki, and E. Rouslahti. 
1987. Arginine-glycine-aspartic acid adhesion receptors. Meth. Enzymol. 
144:475--489. 
29.  Rogalski,  A.  A.,  and  S.  J.  Singer.  1985. An integral  glycoprotein  as- 
sociated with the membrane attachment sites of actin microfilaments. J. 
Cell Biol. 101:785-801. 
30. Rome, L. H., P. N. Bullock, F. Chiappelli, M. C. Cardwell, A. M. Adinolfi, 
and  D.  Swanson.  1986. Synthesis  of  a  myelin-like  membrane  by 
oligodendrocytes in culture.  J.  Neurosci. Res.  15:49-65. 
31. Ruoslahti, E., E. G. Hayman, and M. D. Pierschbacher.  1985. Extracellu- 
lar matrices and cell adhesion. Arteriosclerosis.  5:581-594. 
32. Ruoslahti,  E., and M.  D. Pierschbacher.  1986. Arg-Gly-Asp: a versatile 
cell recognition signal.  Cell. 44:517-518. 
33.  Ruoslahti,  E., and M.  D. Pierschbacher.  1987. New perspectives in cell 
adhesion:  RGD and Integrins.  Science  (Wash. DC). 238:491-497. 
34. Sarlieve, L. L., M. Fabre,  J. Susz, and J. M. Matthieu.  1983. Investiga- 
tions on myelination in vitro: "myelin-like" or premyelin membrane struc- 
tures in cultures of dissociated brain cells from embryonic mice. J. Neu- 
rosci. Res.  10:191-216. 
35.  Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, 
M.  D. Provenzano,  E.  K. Fujimoto,  N.  M.  Goeke,  B.  J.  Olson,  and 
D. C.  Klenk. 1985. Measurement of protein using bicinchoninic acid. 
Analyt.  Biochem.  150:76-85. 
36.  Szuchet, S., S. H. Yim, and S. Monsma.  1983. Lipid metabolism of iso- 
lated oligodendrocytes maintained in long-term culture mimics events as- 
sociated with myelinogenesis.  Proc. Natl. Acad.  Sci. USA. 80:7019- 
7023. 
37.  Towbin, H., T. Staehelim, and J. Gordon.  1979. Electrophoretic transfer 
of proteins from polyacrylamide gels to nitrocellulose sheets: procedure 
and some applications.  Proc.  Natl. Acad. Sci. USA. 76:4350-4354. 
38. Vartanian,  T.,  S.  Szuchet,  G.  Dawson,  and  A.  T.  Campagnoni.  1986. 
Oligodendrocyte  adhesion  activates  protein  kinase  C-mediated  phos- 
phorylation  of myelin basic  protein.  Science (Wash. DC). 234:1395- 
1398. 
39. Walker,  A. G., J. A. Chapman, and M. G. Rumsby.  1985. Immunocyto- 
The Journal of Cell Biology, Volume  107, 1988  1558 chemical demonstration of glial-neuronal interactions and myelinogene- 
sis in subcultures of rat brain cells. J.  Neuroimmunol.  9:159-177. 
40, Yamada, K. M. 1983. Cell surface interactions with extracellular materials. 
Annu.  Rev.  Biochem.  52:761-799. 
41. Yamada, K. M., S. S. Yamada, and I. Pastan. 1976. Cell surface protein 
partially restores morphology, adhesiveness, and contact inhibition  of 
movement to transformed fibroblasts.  Proc. Natl. Acad. Sci. USA. 73: 
1217-1221. 
42. Yim, S. H., S. Szuchet, and P. E. Polak. 1986. Cultured oligodendrocytes: 
a role for cell-substratum interaction in phenotypic expression. J. Biol. 
Chem. 261:11808-11815. 
43. Zeller, N. K., T. N. Behar, M.  E.  Dubois-Dalcq, and R. A. Lazzarini. 
1985. The timely expression of myelin basic protein gene in cultured rat 
brain oligodendrocytes is independent of continuous neuronal influences. 
J.  Neurosci.  5:2955-2962. 
Cardwell and Rome II GRGDSP Inhibits Synthesis of Myelin  1559 